tweetindex
EN

Longevity Technology

@LongevityTech · London · joined 04 Dec 2018

Daily news and insights on research, investments and technologies that extend life and improve the quality of that extended life. #Longevity

18 694Followers
2 284Following
6 012Posts total
4.1KViews on collected posts

Latest posts

850 patients signed up for an Alzheimer’s trial needing 760. For @AnnovisBio, that’s the good kind of surprise The pivotal trial has already exceeded its recruitment target, a key milestone for the biotech https://t.co/v8sCTDdyl8 #longevity #alzheimers #biotech #geroscience ht 1.1K views · 6 likes · 2 reposts · 1 replies Open on X →
Sergey Young, Founder of BOLD Longevity Growth Fund, on what makes LIC different: bringing science, technology and capital together. 2.5 days in Gstaad with 30+ speakers and investors actively deploying into longevity. Learn more and apply: https://t.co/nG6rbBVg3U #LIC2026 htt 665 views · 6 likes · 1 reposts · 1 replies Open on X →
@Veradermics has raised $819.9m as it races to become the first company with an FDA-approved oral drug for hair loss. Late-stage trial data could determine whether its ambition becomes reality https://t.co/aHR8ERiKcl #longevity #hairloss #biotech #drugdevelopment #clinicaltrial 644 views · 0 likes · 0 reposts · 1 replies Open on X →
THPharm is using AI to find new uses for a drug already in Phase 3 trials, turning proven biology into a search for new therapeutic opportunities. https://t.co/ayC7jPeXZE #longevity #ai #drugdevelopment #biotech #metabolicdisease @InSilicoMeds https://t.co/uRttkVc8xh 891 views · 9 likes · 5 reposts · 1 replies Open on X →
USPTO patent protection strengthens @AlterityT’s ATH434 Parkinson’s investment case through 2045, supporting its long-term development and commercial potential. https://t.co/fpNi01qobG #longevity #parkinsonsdisease #biotech #investment #patents https://t.co/I70rscIcp6 826 views · 4 likes · 1 reposts · 1 replies Open on X →

Against accounts of the same size

5 posts from the last 90 days, next to the 10K–100K follower range. ordinary reach for its size, weaker reaction than most.

Median views826this account950median for 10K–100K
Reach, %4.42%this account3.57%median for 10K–100K
Engagement, %0.86%this account1.96%median for 10K–100K
MetricThis accountMedian for 10K–100KRatio
Median views per post8269500.87×
Reach (views ÷ followers)4.42%3.57%1.24×
Engagement rate0.86%1.96%0.44×

Others in this range →   Compare with another account →   How these benchmarks are built →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

8263 Sep
891
6444 Sep
665
1.1K

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.73%3 Sep
1.68%
0.16%4 Sep
1.50%
0.86%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.96%.

What the audience does

Likes55.6%25 in total
Reposts20.0%9 in total
Replies11.1%5 in total
Quotes4.4%2 in total
Bookmarks8.9%4 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Similar accounts